FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. have landed in the FDA’s crosshairs thanks to quality shortfalls, poor testing standards ...
Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.
Artificial intelligence (AI) is the most important technology of our time, one that is rapidly transforming economies and societies. Yet, its implementation for productive applications varies widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback